文献速递心力衰竭与心肌病心律失常

基于心脏磁共振对特发性扩张型心肌病进行风险分层

Towards cardiac MRI based risk stratification in idiopathic dilated cardiomyopathy.
PubMed 文献 · Heart · 2018-10-30

本文综述了当前指南以左室射血分数(EF)<35%作为扩张型心肌病(DCM)植入式心律转复除颤器(ICD)选择标准,但多数心脏性猝死(SCD)发生在EF>35%者中。心脏磁共振(CMR)通过钆对比剂延迟强化、参数映射和特征追踪可检测心肌纤维化,其中约30%的DCM患者存在壁内纤维化,且纤维化与SCD相关。CMR提供的额外信息有助于改善DCM的风险分层。

要点

  • 当前ICD选择标准基于EF<35%,但多数SCD发生在EF>35%的DCM患者中。
  • CMR延迟强化检测到约30%的DCM患者存在壁内纤维化,纤维化与SCD相关。
  • 无纤维化的DCM患者SCD风险较低,CMR工具可在EF之上提供增量价值。

核心结论

  • CMR具有多种工具可在EF之上提供增量价值,以改善DCM的风险分层、结局和资源利用。

研究设计与样本

  • 本文为综述,检索范围未在摘要中明确报告。

主要发现

  • Meta分析显示DCM患者一级预防ICD有生存获益,但无随机试验显示包括最新Danish研究在内的总死亡率显著降低。
  • 延迟钆增强检测到约30%的DCM患者存在壁内纤维化,三项Meta分析显示纤维化与SCD相关,无纤维化者SCD风险低。
  • T1映射和细胞外容积(ECV)可显示弥漫性心肌纤维化,ECV和原生T1升高与更差结局相关,但与SCD的关系尚未充分研究。

关键数值与推荐

  • 当前指南推荐基于EF<35%选择ICD植入。
  • 延迟钆增强检测到约30%的DCM患者存在壁内纤维化。

临床怎么用

  • 对于DCM患者,除EF外可考虑使用CMR评估心肌纤维化以辅助SCD风险分层。
  • 无纤维化的DCM患者SCD风险较低,可能有助于识别ICD获益有限的人群。

局限性

  • ECV和原生T1与SCD的关系尚未充分研究。
  • 需要更多研究来验证CMR在风险分层中的价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sudden cardiac death (SCD) secondary to arrhythmia remains a risk in those with dilated cardiomyopathy (DCM), an implantable cardiac defibrillator (ICD) is an effective strategy to prevent SCD. Current guidelines recommend selection for ICD based on ejection fraction (EF) less than 35%, however, most SCD occurs in those with EF>35%. Although meta-analysis has demonstrated a survival benefit for primary prevention ICD in DCM, no randomised trial has shown a significant reduction in overall mortality including the most recent 'Danish Study to Assess the Efficacy of ICDs in Patients With Non-Ischemic Systolic Heat Failure on Mortality' study. Clearly, a more sophisticated selection strategy is required. Cardiac MRI (CMR) is an ideal non-invasive imaging technique which allows calculation of EF as well as tissue characterisation with gadolinium contrast, parametric mapping and feature tracking. Late gadolinium enhancement detects mid-wall fibrosis in approximately 30% of those with DCM, three meta-analyses have demonstrated an association between fibrosis in DCM and SCD, and those without fibrosis are at low risk of SCD. T1 mapping and extracellular volume (ECV) calculation are methods of demonstrating diffuse fibrosis in the myocardium. Raised ECV and native T1 have been associated with worse outcomes but the relationship to SCD has not been well studied. Undoubtedly, more research is required but CMR has several tools which offer incremental value above EF to improve risk stratification and consequent outcomes and resource utilisation in those with DCM.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Brown PF, Miller C, Di Marco A, et al. Towards cardiac MRI based risk stratification in idiopathic dilated cardiomyopathy. Heart. 2018. PMID: 30377260. doi:10.1136/heartjnl-2018-313767

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。